Pluri Overview
Latest ROE for Pluri: 108.77% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow108.77%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Pluri (PLUR) currently reports a ROE of 108.77%. That is above the Healthcare sector average of 20.77%. Use the charts on this page to explore Pluri's ROE history and peer comparisons.
Pluri's ROE of 108.77% is higher than the Healthcare sector average of 20.77%. That is roughly 423.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Pluri's current 108.77% should be judged against Healthcare norms (sector average: 20.77%) and against PLUR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 108.77%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.77%. From there, open related valuation or income-statement pages for Pluri, and consider following PLUR for alerts when major investors trade the stock.
Pluri is classified in the Healthcare sector. On ROE, it currently shows 108.77% versus a sector average near 20.77%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLUR with unrelated industries.
